Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein-Lysine 6-Oxidase | 43 | 2020 | 64 | 5.910 |
Why?
|
Amino Acid Oxidoreductases | 20 | 2015 | 33 | 3.250 |
Why?
|
Extracellular Matrix | 9 | 2020 | 111 | 1.200 |
Why?
|
Gene Expression Regulation, Enzymologic | 12 | 2013 | 160 | 1.060 |
Why?
|
Epithelial Cells | 5 | 2014 | 366 | 0.940 |
Why?
|
Cell Differentiation | 3 | 2020 | 562 | 0.900 |
Why?
|
Signal Transduction | 6 | 2020 | 1802 | 0.790 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2015 | 176 | 0.750 |
Why?
|
Malvaceae | 1 | 2019 | 4 | 0.740 |
Why?
|
Cell Communication | 1 | 2020 | 93 | 0.720 |
Why?
|
Inflammation | 2 | 2019 | 577 | 0.710 |
Why?
|
Elastin | 11 | 2006 | 37 | 0.660 |
Why?
|
Plant Extracts | 2 | 2019 | 250 | 0.640 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 137 | 0.640 |
Why?
|
Alopecia | 2 | 2008 | 9 | 0.600 |
Why?
|
Phenotype | 9 | 2013 | 650 | 0.600 |
Why?
|
Skin | 5 | 2005 | 173 | 0.590 |
Why?
|
Chromosome Mapping | 9 | 2007 | 159 | 0.570 |
Why?
|
Skin Diseases | 2 | 2007 | 32 | 0.570 |
Why?
|
Head and Neck Neoplasms | 4 | 2015 | 73 | 0.570 |
Why?
|
Molecular Sequence Data | 19 | 2008 | 1490 | 0.560 |
Why?
|
Humans | 68 | 2024 | 34853 | 0.510 |
Why?
|
Exfoliation Syndrome | 1 | 2014 | 13 | 0.510 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2004 | 45 | 0.510 |
Why?
|
Immunohistochemistry | 14 | 2010 | 859 | 0.500 |
Why?
|
Membrane Proteins | 2 | 2008 | 486 | 0.490 |
Why?
|
Speech Disorders | 1 | 2013 | 2 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2015 | 781 | 0.470 |
Why?
|
Glaucoma, Open-Angle | 1 | 2014 | 75 | 0.470 |
Why?
|
Language Disorders | 1 | 2013 | 5 | 0.470 |
Why?
|
Language Development | 1 | 2013 | 18 | 0.460 |
Why?
|
RNA, Messenger | 18 | 2012 | 1152 | 0.450 |
Why?
|
Mutation | 8 | 2011 | 1023 | 0.450 |
Why?
|
Animals | 36 | 2020 | 14307 | 0.440 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 115 | 0.440 |
Why?
|
Amino Acid Sequence | 11 | 2008 | 1124 | 0.420 |
Why?
|
Cytoplasm | 3 | 2006 | 135 | 0.410 |
Why?
|
Neoplasm Metastasis | 5 | 2014 | 211 | 0.400 |
Why?
|
Mice | 23 | 2015 | 5668 | 0.390 |
Why?
|
Cell Line | 8 | 2019 | 1289 | 0.390 |
Why?
|
Up-Regulation | 4 | 2008 | 490 | 0.390 |
Why?
|
Enzyme Activation | 4 | 2007 | 423 | 0.390 |
Why?
|
Cell Polarity | 2 | 2011 | 53 | 0.390 |
Why?
|
Promoter Regions, Genetic | 7 | 2008 | 484 | 0.350 |
Why?
|
5' Flanking Region | 1 | 2008 | 4 | 0.340 |
Why?
|
Pharyngeal Neoplasms | 1 | 2008 | 8 | 0.340 |
Why?
|
Laryngeal Neoplasms | 1 | 2008 | 11 | 0.340 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2007 | 283 | 0.330 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2007 | 17 | 0.330 |
Why?
|
Base Sequence | 15 | 2008 | 932 | 0.330 |
Why?
|
Breast Neoplasms | 9 | 2014 | 1426 | 0.320 |
Why?
|
Paxillin | 1 | 2007 | 5 | 0.320 |
Why?
|
Epidermis | 2 | 2004 | 26 | 0.310 |
Why?
|
Cell Movement | 6 | 2014 | 545 | 0.310 |
Why?
|
Hair Diseases | 1 | 2007 | 5 | 0.300 |
Why?
|
Blotting, Western | 7 | 2009 | 834 | 0.300 |
Why?
|
Placental Lactogen | 1 | 2006 | 8 | 0.300 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 70 | 0.290 |
Why?
|
Superoxide Dismutase | 3 | 2004 | 149 | 0.290 |
Why?
|
Skin Aging | 2 | 2005 | 10 | 0.290 |
Why?
|
Brain Neoplasms | 1 | 2007 | 105 | 0.290 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 124 | 0.280 |
Why?
|
Williams Syndrome | 4 | 2000 | 4 | 0.280 |
Why?
|
Astrocytes | 1 | 2007 | 203 | 0.270 |
Why?
|
Fibronectins | 2 | 2005 | 65 | 0.270 |
Why?
|
Female | 36 | 2023 | 19873 | 0.270 |
Why?
|
Breast | 1 | 2006 | 134 | 0.270 |
Why?
|
Myocardium | 2 | 2004 | 224 | 0.270 |
Why?
|
Adenocarcinoma | 2 | 2011 | 239 | 0.270 |
Why?
|
Cell Line, Tumor | 9 | 2011 | 2128 | 0.260 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 181 | 0.260 |
Why?
|
Cyclosporine | 2 | 2004 | 26 | 0.260 |
Why?
|
Elastic Tissue | 2 | 2007 | 7 | 0.260 |
Why?
|
Collagen | 6 | 2009 | 162 | 0.260 |
Why?
|
DNA, Complementary | 6 | 2005 | 175 | 0.260 |
Why?
|
Blotting, Northern | 7 | 2007 | 139 | 0.250 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 97 | 0.250 |
Why?
|
Gene Deletion | 3 | 2000 | 156 | 0.250 |
Why?
|
Transcription, Genetic | 7 | 2008 | 550 | 0.250 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2009 | 605 | 0.250 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2007 | 19 | 0.240 |
Why?
|
Fibroblasts | 5 | 2010 | 252 | 0.240 |
Why?
|
Polymerase Chain Reaction | 10 | 2010 | 430 | 0.230 |
Why?
|
Gene Expression | 5 | 2002 | 639 | 0.230 |
Why?
|
Disease Models, Animal | 8 | 2012 | 1300 | 0.230 |
Why?
|
Central Nervous System | 1 | 2004 | 130 | 0.220 |
Why?
|
Neuroprotective Agents | 2 | 2004 | 231 | 0.220 |
Why?
|
Genetic Markers | 3 | 1997 | 118 | 0.220 |
Why?
|
Male | 25 | 2023 | 18870 | 0.220 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2002 | 8 | 0.220 |
Why?
|
Students, Medical | 1 | 2024 | 121 | 0.210 |
Why?
|
Nitrogen Oxides | 1 | 2001 | 5 | 0.210 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 528 | 0.210 |
Why?
|
Chromosomes, Human, Pair 15 | 2 | 2001 | 5 | 0.210 |
Why?
|
Placenta | 3 | 2013 | 91 | 0.210 |
Why?
|
Microsatellite Repeats | 6 | 2007 | 51 | 0.210 |
Why?
|
Fibrosis | 4 | 2010 | 146 | 0.200 |
Why?
|
Extracellular Matrix Proteins | 3 | 2012 | 68 | 0.200 |
Why?
|
Abortion, Induced | 1 | 2023 | 82 | 0.200 |
Why?
|
Tropoelastin | 4 | 2007 | 13 | 0.200 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 72 | 0.190 |
Why?
|
Mice, Inbred BALB C | 5 | 2014 | 649 | 0.190 |
Why?
|
Cadherins | 2 | 2014 | 82 | 0.180 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 52 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 12 | 0.180 |
Why?
|
Catalysis | 4 | 2009 | 162 | 0.180 |
Why?
|
Brain Ischemia | 1 | 2001 | 179 | 0.180 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 968 | 0.180 |
Why?
|
Interleukin-1beta | 1 | 2019 | 66 | 0.180 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 1999 | 2 | 0.180 |
Why?
|
Procollagen | 1 | 1999 | 3 | 0.180 |
Why?
|
Polymorphism, Genetic | 2 | 1997 | 165 | 0.170 |
Why?
|
Aminopropionitrile | 6 | 2013 | 13 | 0.170 |
Why?
|
Ischemic Attack, Transient | 3 | 2003 | 20 | 0.160 |
Why?
|
DNA Primers | 4 | 2007 | 269 | 0.160 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 200 | 0.160 |
Why?
|
Mice, Inbred C57BL | 6 | 2014 | 1530 | 0.160 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 210 | 0.160 |
Why?
|
Transcription Factors | 4 | 2008 | 653 | 0.160 |
Why?
|
Sequence Deletion | 3 | 2007 | 87 | 0.160 |
Why?
|
Cytokines | 2 | 2019 | 569 | 0.160 |
Why?
|
Exons | 6 | 2000 | 80 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 325 | 0.160 |
Why?
|
Dinucleotide Repeats | 1 | 1997 | 1 | 0.150 |
Why?
|
Connective Tissue Diseases | 1 | 1997 | 4 | 0.150 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 600 | 0.150 |
Why?
|
Sequence Analysis, DNA | 5 | 2010 | 455 | 0.150 |
Why?
|
Lysine | 3 | 2005 | 104 | 0.150 |
Why?
|
NF-kappa B | 1 | 2019 | 306 | 0.150 |
Why?
|
Introns | 4 | 1999 | 67 | 0.150 |
Why?
|
Heterozygote | 3 | 2011 | 91 | 0.150 |
Why?
|
Colorectal Neoplasms | 1 | 2002 | 413 | 0.150 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2005 | 249 | 0.140 |
Why?
|
Cell Adhesion | 2 | 2008 | 209 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2007 | 49 | 0.140 |
Why?
|
Mice, Mutant Strains | 2 | 2007 | 78 | 0.140 |
Why?
|
Macrophages | 1 | 2019 | 431 | 0.140 |
Why?
|
Adult | 10 | 2023 | 11034 | 0.140 |
Why?
|
Protein Structure, Tertiary | 3 | 2005 | 383 | 0.140 |
Why?
|
Hominidae | 1 | 1995 | 11 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2015 | 16 | 0.130 |
Why?
|
Loss of Heterozygosity | 2 | 2007 | 18 | 0.130 |
Why?
|
Microscopy, Fluorescence | 2 | 2006 | 240 | 0.130 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 465 | 0.130 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1997 | 29 | 0.130 |
Why?
|
Rats | 8 | 2004 | 3261 | 0.120 |
Why?
|
Placentation | 1 | 2013 | 7 | 0.120 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2008 | 32 | 0.120 |
Why?
|
Trophoblasts | 1 | 2013 | 22 | 0.120 |
Why?
|
Neoplasm Invasiveness | 4 | 2008 | 247 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 166 | 0.120 |
Why?
|
Plasmids | 2 | 2003 | 233 | 0.120 |
Why?
|
Recombinant Proteins | 4 | 2007 | 485 | 0.120 |
Why?
|
Mice, Transgenic | 4 | 2004 | 608 | 0.120 |
Why?
|
PPAR gamma | 1 | 2013 | 49 | 0.120 |
Why?
|
Gene Dosage | 2 | 2007 | 74 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2015 | 151 | 0.110 |
Why?
|
Yersinia enterocolitica | 1 | 1992 | 2 | 0.110 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1992 | 13 | 0.110 |
Why?
|
Genetic Association Studies | 1 | 2013 | 102 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2012 | 10 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2012 | 16 | 0.110 |
Why?
|
Transforming Growth Factor beta | 2 | 2008 | 183 | 0.110 |
Why?
|
Pregnancy | 7 | 2023 | 1503 | 0.110 |
Why?
|
Mammary Glands, Human | 2 | 2009 | 39 | 0.110 |
Why?
|
Aged | 5 | 2007 | 6448 | 0.110 |
Why?
|
Lung | 3 | 2007 | 413 | 0.110 |
Why?
|
Down-Regulation | 3 | 2015 | 420 | 0.110 |
Why?
|
Transfection | 3 | 2008 | 496 | 0.110 |
Why?
|
GATA3 Transcription Factor | 1 | 2011 | 4 | 0.110 |
Why?
|
Neoplasms, Basal Cell | 1 | 2011 | 2 | 0.100 |
Why?
|
DNA Replication | 1 | 1992 | 148 | 0.100 |
Why?
|
Muscular Diseases | 1 | 2011 | 20 | 0.100 |
Why?
|
Mutant Proteins | 1 | 2011 | 48 | 0.100 |
Why?
|
Collagen Type IV | 1 | 2011 | 48 | 0.100 |
Why?
|
Nerve Degeneration | 2 | 2003 | 101 | 0.100 |
Why?
|
Escherichia coli | 2 | 2003 | 436 | 0.100 |
Why?
|
Amine Oxidase (Copper-Containing) | 2 | 2008 | 5 | 0.100 |
Why?
|
Hyperglycemia | 2 | 2003 | 53 | 0.100 |
Why?
|
Azacitidine | 2 | 2009 | 21 | 0.100 |
Why?
|
Dogs | 2 | 2014 | 138 | 0.100 |
Why?
|
DNA | 4 | 2008 | 549 | 0.100 |
Why?
|
Dermis | 1 | 2010 | 8 | 0.100 |
Why?
|
Atherosclerosis | 1 | 2012 | 131 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2008 | 56 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2008 | 15 | 0.100 |
Why?
|
Survival Rate | 2 | 2001 | 310 | 0.100 |
Why?
|
Neoplasms | 1 | 2020 | 1033 | 0.100 |
Why?
|
Pseudoxanthoma Elasticum | 2 | 2000 | 28 | 0.090 |
Why?
|
Integrins | 1 | 2009 | 49 | 0.090 |
Why?
|
Rats, Wistar | 4 | 2003 | 202 | 0.090 |
Why?
|
DNA Mutational Analysis | 3 | 2010 | 89 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2005 | 984 | 0.090 |
Why?
|
Glutathione Transferase | 2 | 2008 | 83 | 0.090 |
Why?
|
Aortic Valve Stenosis | 3 | 1999 | 23 | 0.090 |
Why?
|
Middle Aged | 6 | 2008 | 9642 | 0.080 |
Why?
|
Hydrogen Peroxide | 2 | 2008 | 181 | 0.080 |
Why?
|
Child | 4 | 2007 | 2875 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2008 | 68 | 0.080 |
Why?
|
Genes | 3 | 1999 | 58 | 0.080 |
Why?
|
Malaria Vaccines | 1 | 2008 | 20 | 0.080 |
Why?
|
Pedigree | 5 | 2000 | 64 | 0.080 |
Why?
|
Biliary Atresia | 1 | 2007 | 4 | 0.080 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2007 | 5 | 0.080 |
Why?
|
Astrocytoma | 1 | 2007 | 13 | 0.080 |
Why?
|
Models, Genetic | 2 | 2005 | 149 | 0.080 |
Why?
|
Cytogenetic Analysis | 1 | 2007 | 5 | 0.080 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2007 | 4 | 0.080 |
Why?
|
Drosophila | 2 | 2011 | 133 | 0.080 |
Why?
|
Mesoderm | 1 | 2007 | 70 | 0.080 |
Why?
|
Sebaceous Glands | 1 | 2007 | 3 | 0.080 |
Why?
|
Gene Library | 2 | 1999 | 55 | 0.080 |
Why?
|
Muscle, Smooth | 2 | 2005 | 51 | 0.080 |
Why?
|
Vaginal Diseases | 1 | 2007 | 9 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2008 | 112 | 0.080 |
Why?
|
CpG Islands | 1 | 2007 | 91 | 0.080 |
Why?
|
Pelvis | 1 | 2007 | 14 | 0.080 |
Why?
|
Hypertrophy | 1 | 2007 | 31 | 0.080 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2007 | 22 | 0.080 |
Why?
|
Immunotherapy | 1 | 2008 | 91 | 0.070 |
Why?
|
Keratinocytes | 1 | 2007 | 65 | 0.070 |
Why?
|
Postpartum Period | 1 | 2007 | 59 | 0.070 |
Why?
|
Aspergillus nidulans | 1 | 2006 | 7 | 0.070 |
Why?
|
Germination | 1 | 2006 | 7 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2005 | 286 | 0.070 |
Why?
|
Morinda | 1 | 2006 | 9 | 0.070 |
Why?
|
Blood | 1 | 2006 | 32 | 0.070 |
Why?
|
Cell Division | 1 | 2006 | 296 | 0.070 |
Why?
|
Progeria | 1 | 2005 | 9 | 0.070 |
Why?
|
Armadillo Domain Proteins | 1 | 2005 | 2 | 0.070 |
Why?
|
Homeostasis | 1 | 2007 | 172 | 0.070 |
Why?
|
Kinetics | 2 | 2005 | 650 | 0.070 |
Why?
|
Myoblasts | 1 | 2005 | 25 | 0.070 |
Why?
|
Scleroderma, Systemic | 1 | 2005 | 17 | 0.070 |
Why?
|
Euchromatin | 1 | 2005 | 6 | 0.070 |
Why?
|
Salivary Glands | 1 | 2005 | 12 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 49 | 0.070 |
Why?
|
Pericytes | 1 | 2005 | 21 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2005 | 54 | 0.070 |
Why?
|
Physical Chromosome Mapping | 2 | 2002 | 10 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 522 | 0.070 |
Why?
|
Protein Binding | 2 | 2005 | 913 | 0.070 |
Why?
|
Animals, Genetically Modified | 1 | 2005 | 93 | 0.060 |
Why?
|
Immunoblotting | 1 | 2005 | 170 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 195 | 0.060 |
Why?
|
Cell Lineage | 1 | 2005 | 88 | 0.060 |
Why?
|
Organ Specificity | 2 | 1995 | 123 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2015 | 897 | 0.060 |
Why?
|
Muscle Weakness | 1 | 2004 | 7 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2007 | 608 | 0.060 |
Why?
|
Carcinoma | 1 | 2005 | 94 | 0.060 |
Why?
|
Genome | 1 | 2005 | 117 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2004 | 121 | 0.060 |
Why?
|
Saliva | 1 | 2005 | 97 | 0.060 |
Why?
|
Propidium | 1 | 2004 | 18 | 0.060 |
Why?
|
Caspase 3 | 2 | 2001 | 194 | 0.060 |
Why?
|
Candida albicans | 1 | 2006 | 163 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2007 | 1056 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2004 | 125 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 117 | 0.060 |
Why?
|
Chromatin | 1 | 2005 | 164 | 0.060 |
Why?
|
Chorion | 2 | 2001 | 8 | 0.060 |
Why?
|
Decidua | 2 | 2001 | 8 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 1999 | 310 | 0.060 |
Why?
|
Amnion | 2 | 2001 | 17 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 2005 | 168 | 0.060 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2000 | 8 | 0.060 |
Why?
|
Forecasting | 1 | 2024 | 124 | 0.060 |
Why?
|
Cell Survival | 2 | 2004 | 818 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2005 | 351 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2001 | 84 | 0.060 |
Why?
|
Animals, Newborn | 3 | 2015 | 323 | 0.060 |
Why?
|
Culture Media, Serum-Free | 2 | 2006 | 40 | 0.060 |
Why?
|
Protein Conformation | 2 | 2001 | 350 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 50 | 0.060 |
Why?
|
Cell Membrane | 1 | 2005 | 360 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2015 | 1442 | 0.050 |
Why?
|
Longevity | 1 | 2004 | 143 | 0.050 |
Why?
|
Religion | 1 | 2023 | 77 | 0.050 |
Why?
|
Sunlight | 1 | 2002 | 46 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2002 | 66 | 0.050 |
Why?
|
Linear Models | 1 | 2023 | 253 | 0.050 |
Why?
|
Spin Trapping | 1 | 2001 | 1 | 0.050 |
Why?
|
Cyclic N-Oxides | 1 | 2001 | 17 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2003 | 87 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2001 | 12 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2001 | 9 | 0.050 |
Why?
|
Genes, Duplicate | 1 | 2001 | 4 | 0.050 |
Why?
|
Colon | 1 | 2002 | 98 | 0.050 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2001 | 4 | 0.050 |
Why?
|
Aged, 80 and over | 1 | 2007 | 2333 | 0.050 |
Why?
|
DNA Fragmentation | 1 | 2001 | 91 | 0.050 |
Why?
|
Crossing Over, Genetic | 2 | 1999 | 3 | 0.050 |
Why?
|
Rubiaceae | 1 | 2000 | 1 | 0.050 |
Why?
|
Child, Preschool | 2 | 2007 | 1318 | 0.050 |
Why?
|
Cohort Studies | 2 | 2002 | 1422 | 0.050 |
Why?
|
Glycosides | 1 | 2000 | 19 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 2 | 2007 | 162 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1999 | 6 | 0.050 |
Why?
|
Trisaccharides | 1 | 1999 | 10 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2000 | 54 | 0.050 |
Why?
|
Chromosome Breakage | 1 | 1999 | 14 | 0.050 |
Why?
|
Hawaii | 2 | 2024 | 1878 | 0.050 |
Why?
|
Citrus | 1 | 1999 | 12 | 0.050 |
Why?
|
Relaxin | 1 | 1999 | 10 | 0.050 |
Why?
|
Substrate Specificity | 2 | 2003 | 186 | 0.050 |
Why?
|
Thymus Gland | 1 | 2000 | 77 | 0.050 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2000 | 82 | 0.040 |
Why?
|
Carbon Tetrachloride | 1 | 1999 | 5 | 0.040 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1999 | 3 | 0.040 |
Why?
|
Neurons | 2 | 2004 | 1130 | 0.040 |
Why?
|
Prevalence | 1 | 2024 | 1425 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2001 | 249 | 0.040 |
Why?
|
Urinary Bladder | 1 | 1999 | 28 | 0.040 |
Why?
|
Fruit | 1 | 2000 | 159 | 0.040 |
Why?
|
Fatty Acids | 1 | 1999 | 118 | 0.040 |
Why?
|
Alternative Splicing | 1 | 1999 | 82 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 1999 | 51 | 0.040 |
Why?
|
Fibrin | 1 | 1998 | 8 | 0.040 |
Why?
|
Sequence Tagged Sites | 1 | 1997 | 4 | 0.040 |
Why?
|
Schistosomiasis mansoni | 1 | 1998 | 11 | 0.040 |
Why?
|
Stromal Cells | 1 | 1998 | 45 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 1998 | 25 | 0.040 |
Why?
|
Mammary Neoplasms, Animal | 1 | 1998 | 30 | 0.040 |
Why?
|
Extraembryonic Membranes | 1 | 1997 | 6 | 0.040 |
Why?
|
Mitochondria | 1 | 2001 | 454 | 0.040 |
Why?
|
Cattle | 2 | 1998 | 472 | 0.040 |
Why?
|
Alleles | 2 | 1999 | 284 | 0.040 |
Why?
|
RNA | 1 | 1999 | 234 | 0.040 |
Why?
|
Biopsy | 2 | 2010 | 151 | 0.040 |
Why?
|
Meiosis | 1 | 1996 | 60 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1997 | 127 | 0.040 |
Why?
|
Liver | 1 | 1999 | 447 | 0.040 |
Why?
|
Homozygote | 2 | 2011 | 75 | 0.040 |
Why?
|
Osteosarcoma | 1 | 1996 | 24 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 44 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1995 | 42 | 0.030 |
Why?
|
Brain | 1 | 2003 | 1268 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1996 | 257 | 0.030 |
Why?
|
Gestational Age | 2 | 2007 | 190 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1995 | 52 | 0.030 |
Why?
|
Genotype | 4 | 2000 | 641 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1995 | 24 | 0.030 |
Why?
|
Adenosine Monophosphate | 1 | 1995 | 7 | 0.030 |
Why?
|
Aspartic Acid | 1 | 1995 | 46 | 0.030 |
Why?
|
CHO Cells | 1 | 1995 | 107 | 0.030 |
Why?
|
Cricetinae | 1 | 1995 | 217 | 0.030 |
Why?
|
Genetic Variation | 1 | 1997 | 328 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2007 | 871 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2014 | 336 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2013 | 24 | 0.030 |
Why?
|
Glutamic Acid | 1 | 1995 | 115 | 0.030 |
Why?
|
DNA, Recombinant | 1 | 1993 | 16 | 0.030 |
Why?
|
Consensus Sequence | 1 | 1993 | 24 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 1995 | 407 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2005 | 126 | 0.030 |
Why?
|
Thiazolidinediones | 1 | 2013 | 48 | 0.030 |
Why?
|
Gene Silencing | 1 | 2014 | 143 | 0.030 |
Why?
|
Mice, Nude | 1 | 2014 | 323 | 0.030 |
Why?
|
3T3 Cells | 2 | 2008 | 58 | 0.030 |
Why?
|
Chlorpromazine | 1 | 1992 | 3 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2005 | 480 | 0.030 |
Why?
|
Methylene Blue | 1 | 1992 | 5 | 0.030 |
Why?
|
Promethazine | 1 | 1992 | 2 | 0.030 |
Why?
|
Imipramine | 1 | 1992 | 8 | 0.030 |
Why?
|
Transformation, Bacterial | 1 | 1992 | 11 | 0.030 |
Why?
|
Protein Transport | 1 | 2013 | 286 | 0.030 |
Why?
|
Disease Progression | 1 | 2015 | 580 | 0.030 |
Why?
|
Aging | 2 | 2009 | 639 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2012 | 38 | 0.030 |
Why?
|
Lymphocytes | 1 | 1993 | 116 | 0.030 |
Why?
|
Cytochrome c Group | 2 | 2003 | 13 | 0.030 |
Why?
|
Cannabinoids | 1 | 1992 | 54 | 0.030 |
Why?
|
Dentate Gyrus | 2 | 2003 | 39 | 0.030 |
Why?
|
Angiotensin II | 1 | 2012 | 92 | 0.030 |
Why?
|
Basement Membrane | 1 | 2011 | 28 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 1992 | 184 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2011 | 16 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2012 | 129 | 0.030 |
Why?
|
Thiophenes | 1 | 2011 | 31 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1992 | 376 | 0.030 |
Why?
|
Contractile Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
Molecular Structure | 1 | 1992 | 467 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 47 | 0.020 |
Why?
|
Pyrimidines | 1 | 2011 | 112 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2010 | 64 | 0.020 |
Why?
|
Spectrometry, Mass, Fast Atom Bombardment | 2 | 2000 | 6 | 0.020 |
Why?
|
Spectrophotometry, Infrared | 2 | 2000 | 35 | 0.020 |
Why?
|
Glucosides | 2 | 2000 | 15 | 0.020 |
Why?
|
Elasticity | 2 | 2002 | 38 | 0.020 |
Why?
|
Glycoproteins | 1 | 2010 | 100 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 89 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 22 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 63 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2009 | 30 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 707 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2008 | 9 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2000 | 281 | 0.020 |
Why?
|
Osteoblasts | 1 | 2008 | 33 | 0.020 |
Why?
|
Leukoplakia, Oral | 1 | 2008 | 11 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 2008 | 33 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2008 | 63 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2008 | 55 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2008 | 19 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2008 | 21 | 0.020 |
Why?
|
Bone and Bones | 1 | 2008 | 89 | 0.020 |
Why?
|
Epitopes | 1 | 2008 | 145 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 81 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2008 | 81 | 0.020 |
Why?
|
Pancreatic Elastase | 1 | 2007 | 7 | 0.020 |
Why?
|
Prolapse | 1 | 2007 | 2 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 72 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2007 | 31 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2007 | 37 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 31 | 0.020 |
Why?
|
Sheep | 1 | 2007 | 70 | 0.020 |
Why?
|
Operon | 1 | 1987 | 43 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 22 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2008 | 392 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2008 | 235 | 0.020 |
Why?
|
Serine | 1 | 2007 | 72 | 0.020 |
Why?
|
Peroxidase | 1 | 2007 | 50 | 0.020 |
Why?
|
Vagina | 1 | 2007 | 81 | 0.020 |
Why?
|
Cyanobacteria | 1 | 1987 | 23 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 224 | 0.020 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2005 | 8 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 157 | 0.020 |
Why?
|
Plant Proteins | 1 | 1987 | 93 | 0.020 |
Why?
|
Culture Media | 1 | 2006 | 84 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2001 | 30 | 0.020 |
Why?
|
Oxygen | 1 | 2007 | 193 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 298 | 0.020 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2005 | 42 | 0.020 |
Why?
|
Catalase | 1 | 2005 | 106 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2007 | 132 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 126 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2005 | 185 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2010 | 1149 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 133 | 0.020 |
Why?
|
Actins | 1 | 2005 | 142 | 0.020 |
Why?
|
Anterior Horn Cells | 1 | 2004 | 5 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2004 | 60 | 0.020 |
Why?
|
Hindlimb | 1 | 2004 | 26 | 0.020 |
Why?
|
RNA Interference | 1 | 2005 | 225 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2004 | 197 | 0.020 |
Why?
|
Substantia Nigra | 1 | 2004 | 41 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 145 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 152 | 0.020 |
Why?
|
Infant | 1 | 2007 | 1014 | 0.020 |
Why?
|
Proteins | 1 | 1987 | 352 | 0.020 |
Why?
|
Benzylamines | 1 | 2003 | 6 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2003 | 11 | 0.020 |
Why?
|
Quinones | 1 | 2003 | 10 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2003 | 71 | 0.010 |
Why?
|
Activating Transcription Factor 2 | 1 | 2003 | 2 | 0.010 |
Why?
|
Cysteine | 1 | 2003 | 88 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2003 | 23 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2003 | 237 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2003 | 116 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2003 | 20 | 0.010 |
Why?
|
Protein Folding | 1 | 2003 | 121 | 0.010 |
Why?
|
Copper | 1 | 2003 | 101 | 0.010 |
Why?
|
Ear, External | 1 | 2002 | 2 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2003 | 72 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 204 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2002 | 38 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2003 | 53 | 0.010 |
Why?
|
Temperature | 1 | 2003 | 275 | 0.010 |
Why?
|
Body Weight | 1 | 2004 | 404 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1987 | 520 | 0.010 |
Why?
|
Isoenzymes | 1 | 2002 | 149 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 260 | 0.010 |
Why?
|
Motor Activity | 1 | 2004 | 393 | 0.010 |
Why?
|
Neocortex | 1 | 2001 | 26 | 0.010 |
Why?
|
Thalamus | 1 | 2001 | 29 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2001 | 6 | 0.010 |
Why?
|
Contig Mapping | 1 | 2001 | 8 | 0.010 |
Why?
|
Abortion, Legal | 1 | 2001 | 6 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2001 | 35 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2001 | 18 | 0.010 |
Why?
|
Age Factors | 1 | 2004 | 1007 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2001 | 186 | 0.010 |
Why?
|
Optical Rotation | 1 | 2000 | 1 | 0.010 |
Why?
|
Caspases | 1 | 2001 | 132 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 2000 | 37 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 2000 | 46 | 0.010 |
Why?
|
Consanguinity | 1 | 2000 | 5 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 4012 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2001 | 90 | 0.010 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2000 | 75 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 396 | 0.010 |
Why?
|
TATA Box | 1 | 1999 | 4 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1999 | 2 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1999 | 19 | 0.010 |
Why?
|
Lod Score | 1 | 1999 | 4 | 0.010 |
Why?
|
Rutin | 1 | 1999 | 3 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2001 | 99 | 0.010 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1999 | 7 | 0.010 |
Why?
|
Pyrans | 1 | 1999 | 9 | 0.010 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2000 | 42 | 0.010 |
Why?
|
Pseudogenes | 1 | 1999 | 8 | 0.010 |
Why?
|
Esters | 1 | 1999 | 28 | 0.010 |
Why?
|
5' Untranslated Regions | 1 | 1999 | 14 | 0.010 |
Why?
|
Phosphorylation | 1 | 2003 | 878 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 1999 | 39 | 0.010 |
Why?
|
Response Elements | 1 | 1999 | 52 | 0.010 |
Why?
|
Time Factors | 1 | 2004 | 1681 | 0.010 |
Why?
|
Multigene Family | 1 | 1999 | 105 | 0.010 |
Why?
|
Computational Biology | 1 | 2001 | 275 | 0.010 |
Why?
|
Haplotypes | 1 | 1999 | 152 | 0.010 |
Why?
|
Compliance | 1 | 1999 | 9 | 0.010 |
Why?
|
RNA Splicing | 1 | 1999 | 36 | 0.010 |
Why?
|
Liver Diseases, Parasitic | 1 | 1998 | 1 | 0.010 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1998 | 2 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 794 | 0.010 |
Why?
|
Desmosine | 1 | 1997 | 1 | 0.010 |
Why?
|
Hippocampus | 1 | 2001 | 546 | 0.010 |
Why?
|
Luciferases | 1 | 1997 | 62 | 0.010 |
Why?
|
Binding Sites | 1 | 1999 | 597 | 0.010 |
Why?
|
Drug Stability | 1 | 1997 | 110 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1997 | 138 | 0.010 |
Why?
|
Haploidy | 1 | 1996 | 16 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 5035 | 0.010 |
Why?
|
Hela Cells | 1 | 1998 | 344 | 0.010 |
Why?
|
Gene Frequency | 1 | 1997 | 155 | 0.010 |
Why?
|
Amino Acids | 1 | 1997 | 139 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2000 | 638 | 0.010 |
Why?
|
Aorta | 1 | 1997 | 161 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1998 | 298 | 0.010 |
Why?
|
Apoptosis | 1 | 2001 | 1317 | 0.010 |
Why?
|
RNA Caps | 1 | 1993 | 12 | 0.010 |
Why?
|
Poly A | 1 | 1993 | 33 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 1534 | 0.010 |
Why?
|
Gene Amplification | 1 | 1987 | 24 | 0.000 |
Why?
|
Gases | 1 | 1987 | 24 | 0.000 |
Why?
|